CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 175 filers reported holding CARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28 | -37.8% | 16,472 | +2.9% | 0.00% | – |
| Q2 2023 | $45 | -42.3% | 16,010 | +0.2% | 0.00% | – |
| Q1 2023 | $78 | -76.6% | 15,979 | -48.4% | 0.00% | – |
| Q4 2022 | $333 | -99.9% | 30,979 | +19.2% | 0.00% | – |
| Q3 2022 | $243,000 | +29.3% | 26,000 | +26.1% | 0.00% | – |
| Q2 2022 | $188,000 | -51.0% | 20,611 | -34.8% | 0.00% | – |
| Q1 2022 | $384,000 | -1.3% | 31,600 | -1.2% | 0.00% | – |
| Q4 2021 | $389,000 | -21.4% | 31,976 | -0.3% | 0.00% | -100.0% |
| Q3 2021 | $495,000 | -10.5% | 32,065 | -17.3% | 0.00% | 0.0% |
| Q2 2021 | $553,000 | -33.7% | 38,752 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $834,000 | +43.5% | 38,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $581,000 | +18.8% | 38,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $489,000 | -25.6% | 38,400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $657,000 | +29.6% | 38,400 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $507,000 | -18.1% | 38,400 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $619,000 | -12.1% | 38,400 | -0.3% | 0.00% | 0.0% |
| Q3 2019 | $704,000 | -7.7% | 38,500 | +8.5% | 0.00% | 0.0% |
| Q2 2019 | $763,000 | +26.7% | 35,500 | +15.6% | 0.00% | 0.0% |
| Q1 2019 | $602,000 | +50.9% | 30,700 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $399,000 | -44.7% | 30,700 | +2.0% | 0.00% | 0.0% |
| Q3 2018 | $721,000 | +25.2% | 30,100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $576,000 | +54.4% | 30,100 | 0.0% | 0.00% | – |
| Q1 2018 | $373,000 | +1.4% | 30,100 | 0.0% | 0.00% | – |
| Q4 2017 | $368,000 | -10.7% | 30,100 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $412,000 | -11.0% | 30,100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $463,000 | +0.7% | 30,100 | +20.4% | 0.00% | 0.0% |
| Q1 2017 | $460,000 | +152.7% | 25,001 | +27.6% | 0.00% | – |
| Q4 2016 | $182,000 | +11.0% | 19,600 | 0.0% | 0.00% | – |
| Q3 2016 | $164,000 | +74.5% | 19,600 | 0.0% | 0.00% | – |
| Q2 2016 | $94,000 | -23.0% | 19,600 | 0.0% | 0.00% | – |
| Q1 2016 | $122,000 | -56.1% | 19,600 | +18.8% | 0.00% | – |
| Q4 2015 | $278,000 | +17.8% | 16,500 | 0.0% | 0.00% | – |
| Q3 2015 | $236,000 | +48.4% | 16,500 | +25.9% | 0.00% | – |
| Q2 2015 | $159,000 | – | 13,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
| Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
| Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
| Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
| DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
| Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
| AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
| ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |